These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21482159)

  • 1. Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma.
    Mayayo SL; Prestigio S; Maniscalco L; Rosa G; Aricò A; Maria R; Cavallo F; Ferrone S; Buracco P; Iussich S
    Vet J; 2011 Nov; 190(2):e26-e30. PubMed ID: 21482159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma.
    Wang Y; Sabbatino F; Wang X; Ferrone S
    Methods Mol Biol; 2014; 1102():523-35. PubMed ID: 24258997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial.
    Riccardo F; Tarone L; Camerino M; Giacobino D; Iussich S; Barutello G; Arigoni M; Conti L; Bolli E; Quaglino E; Merighi IF; Morello E; Dentini A; Ferrone S; Buracco P; Cavallo F
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-associated markers in the prognosis of oral canine melanoma.
    Gola C; Maniscalco L; Iussich S; Morello E; Olimpo M; Martignani E; Accornero P; Giacobino D; Mazzone E; Modesto P; Varello K; Aresu L; De Maria R
    Vet Pathol; 2024 Sep; 61(5):721-731. PubMed ID: 38613423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
    Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
    Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A.
    Giudice C; Ceciliani F; Rondena M; Stefanello D; Grieco V
    J Vet Diagn Invest; 2010 May; 22(3):389-94. PubMed ID: 20453212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA.
    Riccardo F; Iussich S; Maniscalco L; Lorda Mayayo S; La Rosa G; Arigoni M; De Maria R; Gattino F; Lanzardo S; Lardone E; Martano M; Morello E; Prestigio S; Fiore A; Quaglino E; Zabarino S; Ferrone S; Buracco P; Cavallo F
    Clin Cancer Res; 2014 Jul; 20(14):3753-62. PubMed ID: 24874834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization.
    Cangul IT; van Garderen E; van der Linde-Sipman JS; van den Ingh TS; Schalken JA
    J Comp Pathol; 2001; 125(2-3):166-73. PubMed ID: 11578133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.
    Koenig A; Wojcieszyn J; Weeks BR; Modiano JF
    Vet Pathol; 2001 Jul; 38(4):427-35. PubMed ID: 11467477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.
    Piras LA; Riccardo F; Iussich S; Maniscalco L; Gattino F; Martano M; Morello E; Lorda Mayayo S; Rolih V; Garavaglia F; De Maria R; Lardone E; Collivignarelli F; Mignacca D; Giacobino D; Ferrone S; Cavallo F; Buracco P
    Vet Comp Oncol; 2017 Sep; 15(3):996-1013. PubMed ID: 27146852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSPG4: a prototype oncoantigen for translational immunotherapy studies.
    Rolih V; Barutello G; Iussich S; De Maria R; Quaglino E; Buracco P; Cavallo F; Riccardo F
    J Transl Med; 2017 Jul; 15(1):151. PubMed ID: 28668095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of immunocytochemical techniques in canine melanoma.
    Höinghaus R; Mischke R; Hewicker-Trautwein M
    J Vet Med A Physiol Pathol Clin Med; 2002 May; 49(4):198-202. PubMed ID: 12069262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell proliferation and expression of connexins differ in melanotic and amelanotic canine oral melanomas.
    Teixeira TF; Gentile LB; da Silva TC; Mennecier G; Chaible LM; Cogliati B; Roman MA; Gioso MA; Dagli ML
    Vet Res Commun; 2014 Mar; 38(1):29-38. PubMed ID: 24126842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and clinical relevance of chondroitin sulfate proteoglycan 4.
    Campoli M; Ferrone S; Wang X
    Adv Cancer Res; 2010; 109():73-121. PubMed ID: 21070915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
    Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
    Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
    Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
    Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma.
    Price MA; Colvin Wanshura LE; Yang J; Carlson J; Xiang B; Li G; Ferrone S; Dudek AZ; Turley EA; McCarthy JB
    Pigment Cell Melanoma Res; 2011 Dec; 24(6):1148-57. PubMed ID: 22004131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain.
    Yang J; Price MA; Wanshura LEC; He J; Yi M; Welch DR; Li G; Conner S; Sachs J; Turley EA; McCarthy JB
    Melanoma Res; 2019 Aug; 29(4):365-375. PubMed ID: 31140988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma.
    Maekawa N; Konnai S; Okagawa T; Nishimori A; Ikebuchi R; Izumi Y; Takagi S; Kagawa Y; Nakajima C; Suzuki Y; Kato Y; Murata S; Ohashi K
    PLoS One; 2016; 11(6):e0157176. PubMed ID: 27276060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype.
    Finotello R; Monné Rodriguez JM; Vilafranca M; Altimira J; Ramirez GA; Haines A; Ressel L
    Vet Comp Oncol; 2017 Dec; 15(4):1393-1402. PubMed ID: 27779366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.